We are live on !
Find out more
XTX Topco Portfolio holdings
AUM
$7.72B
Turnover
39.96%
1-Year Est. Return
32.88%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
–
AUM
$7.72B
AUM Growth
+$1.97B
(+34%)
Cap. Flow
+$1.58B
Cap. Flow % of AUM
Cap. Flow %
20.47%
Top 10 Holdings %
Top 10 Hldgs %
3.84%
Holding
4,912
New
1,139
Increased
1,694
Reduced
1,253
Closed
824
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$41.2M |
| 2 |
Netflix
NFLX
|
+$35.5M |
| 3 |
Intercontinental Exchange
ICE
|
+$29.7M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$29.4M |
| 5 |
PepsiCo
PEP
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$35.4M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.9M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$24.6M |
| 4 |
NVIDIA
NVDA
|
+$23.6M |
| 5 |
Arm
ARM
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.1% |
| 2 | Financials | 15.06% |
| 3 | Industrials | 13.66% |
| 4 | Healthcare | 12% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3826
XBiotech
XBIT
$57.3M
| $30.1K | ﹤0.01% |
13,080
-4,821
| -27% | -$11.7K |
2025 Q2
4 quarters
|
|
3827
Paramount Gold Nevada
PZG
$81M
| $29.7K | ﹤0.01% |
26,055
-54,898
| -68% | -$78.2K |
2025 Q1
5 quarters
|
|
3828
Phaos Technology Holdings (Cayman) Ltd
POAS
$713K
| $29.5K | ﹤0.01% |
7,060
-3,148
| -31% | -$72.9K |
2026 Q1
1 quarter
|
|
3829
E-Power Inc
EPOW
$9.07M
| $29.5K | ﹤0.01% |
1,936
+1,173
| +154% | +$20.5K |
2025 Q4
2 quarters
|
|
3830
RenovoRx
RNXT
$53.7M
| $29.4K | ﹤0.01% |
29,983
-528
| -2% | -$480 |
2025 Q3
3 quarters
|
|
3831
Siebert Financial
SIEB
$75.4M
| $29.3K | ﹤0.01% |
+17,780
| New | +$32.4K |
2026 Q2
0 quarters
|
|
3832
PDS Biotechnology
PDSB
$84.8M
| $29.2K | ﹤0.01% |
33,098
-3,113
| -9% | -$3.3K |
2025 Q3
3 quarters
|
|
3833
Torrid Holdings
CURV
$241M
| $29.1K | ﹤0.01% |
15,585
+2,091
| +15% | +$3.65K |
2026 Q1
1 quarter
|
|
3834
Talphera
TLPH
$52.4M
| $29K | ﹤0.01% |
28,194
+2,447
| +10% | +$2.09K |
2026 Q1
1 quarter
|
|
3835
Xtant Medical Holdings
XTNT
$43.7M
| $28.9K | ﹤0.01% |
68,531
+30,598
| +81% | +$14.7K |
2026 Q1
1 quarter
|
|
3836
Acco Group Holdings
ACCL
$35.2M
| $28.8K | ﹤0.01% |
+17,152
| New | +$25.7K |
2026 Q2
0 quarters
|
|
3837
Axonex AI Group Limited Class A Ordinary Shares
AXNX
$6.48M
| $28.8K | ﹤0.01% |
4,964
+3,299
| +198% | +$24.8K |
2025 Q4
2 quarters
|
|
3838
Lotus Technology
LOT
$200M
| $28.8K | ﹤0.01% |
24,595
-9,025
| -27% | -$11.5K |
2025 Q2
4 quarters
|
|
3839
Click Holdings
CLIK
$6.1M
| $28.4K | ﹤0.01% |
+18,716
| New | +$38.2K |
2026 Q2
0 quarters
|
|
|
LBGJ
3840
Li Bang International
LBGJ
$1.08M
| $28.3K | ﹤0.01% |
+122
| New | +$25.4K |
2026 Q2
0 quarters
|
|
3841
Tvardi Therapeutics
TVRD
$11.5M
| $28.2K | ﹤0.01% |
+14,868
| New | +$46.6K |
2026 Q2
0 quarters
|
|
3842
Mercer International
MERC
$16.3M
| $28K | ﹤0.01% |
42,391
-21,075
| -33% | -$21K |
2026 Q1
1 quarter
|
|
3843
Innate Pharma
IPHA
$156M
| $27.8K | ﹤0.01% |
+15,130
| New | +$25K |
2026 Q2
0 quarters
|
|
|
FBGL
3844
FBS Global
FBGL
$2.93M
| $27.6K | ﹤0.01% |
5,422
-957
| -15% | -$5.57K |
2025 Q4
2 quarters
|
|
3845
BioVie
BIVI
$10.7M
| $27.6K | ﹤0.01% |
14,228
-6,998
| -33% | -$11K |
2025 Q4
2 quarters
|
|
3846
Cherry Hill Mortgage Investment Corp
CHMI
$89.4M
| $27.5K | ﹤0.01% |
11,860
-11,872
| -50% | -$29.7K |
2025 Q4
2 quarters
|
|
3847
Diginex Ltd
DGNX
$33.5M
| $27.5K | ﹤0.01% |
+18,562
| New | +$38.3K |
2026 Q2
0 quarters
|
|
3848
Lixiang Education Holding
LXEH
$2.66M
| $27.3K | ﹤0.01% |
20,072
+17,621
| +719% | +$25.3K |
2026 Q1
1 quarter
|
|
3849
Sagtec Global
SAGT
$18.6M
| $27K | ﹤0.01% |
+21,587
| New | +$30.4K |
2026 Q2
0 quarters
|
|
3850
Allarity Therapeutics
ALLR
$15.4M
| $26.9K | ﹤0.01% |
20,884
-8,083
| -28% | -$11.5K |
2025 Q4
2 quarters
|
|
Similar funds
XTX Topco's Q2 2026 Portfolio in Review
As of Q2 2026, XTX Topco held 4,912 positions worth $7.72B, up 34% from $5.75B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.
XTX Topco deployed $1.58B of net new capital in Q2 2026, opening 1,139 new positions and adding to 1,694 existing holdings. Its largest new stake was Netflix: 403,127 shares worth $28.8M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $29.9M trimmed.
- XTX Topco's largest Q2 2026 buy was Netflix: 403,127 shares worth $28.8M.
- XTX Topco added most to Chevron in Q2 2026, an estimated $41.2M increase.
- XTX Topco's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $29.9M.
- XTX Topco fully exited iShares MSCI South Korea ETF in Q2 2026, selling an estimated $35.4M.
- XTX Topco's ten largest holdings make up 3.8% of its $7.72B portfolio in Q2 2026.
- XTX Topco opened 1,139 new positions and closed 824 in Q2 2026.
- XTX Topco's portfolio value rose 34% quarter-over-quarter to $7.72B.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.